These findings provide a molecular context for understanding the mechanisms by which NLaz/ApoD and Rk/Lgr4 signaling regulate metabolic signaling in obese-like states and suggest that modulation of NLaz/ApoD function might provide a strategy for treatment of metabolic disorders. Here, APOD is linked to metabolic disease.